211364-69-1: Tenofovir Disoproxil Fumarate IP Impurity A
Tenofovir Disoproxil Fumarate IP Impurity A (CAS No: 211364-69-1) Or (8R)-9-(6-Amino-9H-purin-9-yl)-5-hydroxy-8-methyl-2,4,7-trioxa-5-phosphanonanoic Acid 1-Methylethyl Ester 5-Oxide, Tenofovir Disoproxil Fumarate is an is initially metabolized to tenofovir, which is used for long-term treatment of HIV infection.
Additional information on CAS 211364-69-1
VL470024
211364-69-1
C14H22N5O7P
403.33
Tenofovir
({[(R)-1-(6-Amino-9H-purin-9-yl)propan-2-yloxy]methyl}(hydroxy) phosphoryl oxy)methyl isopropyl carbonate
Tenofovir Isoproxil Monoester/ Tenofovir Monosoproxil/ Tenofovir Mono-POC-PMPA
Sci-Hub, Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials, 10.1016/S0140-6736(15)60616-X. (2015). Retrieved January 24, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/S0140-6736(15)60616-X
In-stock
